A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention
- 1 December 2002
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 40 (11) , 1943-1950
- https://doi.org/10.1016/s0735-1097(02)02531-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Defining the Optimal Activated Clotting Time During Percutaneous Coronary InterventionCirculation, 2001
- Minimal heparinization in coronary angioplasty—how much heparin is really warranted?The American Journal of Cardiology, 2000
- Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Early Increase of von Willebrand Factor Predicts Adverse Outcome in Unstable Coronary Artery DiseaseCirculation, 1998
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)Journal of the American College of Cardiology, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Predictors of groin complications after balloon and new-device coronary interventionThe American Journal of Cardiology, 1995
- Pharmacokinetics and biodistribution of technetium 99m labelled standard heparin and a low molecular weight heparin (enoxaparin) after intravenous injection in normal volunteersBritish Journal of Haematology, 1991